I haven't done any models, I think most fundamental models are useless at this point. Neverthless, $4B market cap right now is probably building in a lot of ponatinib sales for the foreseeable future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.